Abstract:The health-improving functions of bioactive flavonoids in vitro and in vivo are often limited by their low stability, which could be counteracted by the application of proteins as carriers of flavonoids. Clarification of the mechanism of protein–ligand interaction is crucial for the encapsulation of bioactive components. Herein, common plasma proteins [i.e., bovine serum albumin (BSA), human serum albumin (HSA), human immunoglobulin G (IgG) and fibrinogen (FG)] were compared for their binding characteristics to quercetin, the main component of flavonoids in human diet, in the absence and presence of free Cu 2+ (an accelerator for flavonoids' instability) using multi-spectroscopic and computational methods. As a flexible open structure of proteins, both BSA and HSA were found to be the most promising carriers for quercetin and Cu 2+ with an affinity on the order of 10 4 M −1 . HSA-diligand complex (i.e., HSA-quercetin-Cu 2+ ) was successfully generated when both quercetin and Cu 2+ were added to the HSA solution. The stability and free radical scavenging activity of bioactive quercetin during incubation was promoted in the HSA-diligand complex relative to quercetin-Cu 2+ complex. Quercetin/Cu 2+ system could induce the formation of reactive oxygen species such as hydrogen peroxide (H 2 O 2 ) and hydroxide radical (·OH), which were significantly suppressed upon HSA binding. Consistently, the cytotoxicity of the quercetin/Cu 2+ system to endothelial cells was reduced in the HSA-diligand complex. These results demonstrate the possibility of developing serum albumin-based carriers for the protection of bioactive flavonoids in their nutritional application.

The binding and structural association of flavonoids with bovine serum albumin

Comparative Binding Affinities Of Flavonoid Phytochemicals With Bovine Serum Albumin

Studies on interaction between flavonoids and bovine serum albumin by spectral methods

Characterization of the Interactions Between Natural Flavonoid Compounds and Bovine Serum Albumin by Capillary Electrophoresis and Fluorescence Method

Interaction Between Serum Albumin and Four Flavones by Fluorescence Spectroscopy and Molecular Docking

Study on Interactions of Phenolic Acid-Like Drug Candidates with Bovine Serum Albumin by Capillary Electrophoresis and Fluorescence Spectroscopy

Investigation of the Interaction Between Flavonoids and Human Serum Albumin

In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods.

Characterization of interactions of simvastatin, pravastatin, fluvastatin, and pitavastatin with bovine serum albumin: multiple spectroscopic and molecular docking.

Structure-affinity relationship of the binding of phenolic acids and their derivatives to bovine serum albumin

Study of the Interaction Between 4 (3H)-Quinazolinone Derivative Containing Dithiocarbamate and Bovine Serum Albumin by Fluorescence Spectroscopy

Investigation of the Interaction Between Bovine Serum Albumin with Paeoniflorin and Loganin

Binding Interaction of Atorvastatin with Bovine Serum Albumin: Spectroscopic Methods and Molecular Docking.

A Fluorescence Study on the Interaction of 1,3,5-Trihydroxybenzene with BSA

Fluorescence spectral characteristics of interaction between organic UV filters and bovine serum albumin

Multiple spectroscopic and computational studies on binding interaction of 2-phenylamino-4-phenoxyquinoline derivatives with bovine serum albumin

Fluorescence Study on the Interaction of New Herbicide ZJ0777 and Bovine Serum Albumin

Analysis of Binding Interaction Between Bovine Serum Albumin and the Cobalt(Ii) Complex with Salicylaldehyde-2-Phenylquinoline-4-Carboylhydrazone

Spectroscopic analyses on interaction of o-Vanillin-D-Phenylalanine, o-Vanillin-L-Tyrosine and o-Vanillin-L-Levodopa Schiff Bases with bovine serum albumin (BSA)

Serum albumin acted as an effective carrier to improve the stability of bioactive flavonoid

The binding selectivity of quercetin and its structure-related polyphenols to human serum albumin using a fluorescent dye cocktail for multiplex drug-site mapping